Home > Insider Trading > Filing (0000899243-21-011155)

Filing Details

Accession Number:: 0000899243-21-011155
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-11 16:43:50
Reporting Period:: 2021-03-09

Accepted Time:: 2021-03-11 16:43:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1754068	Allovir Inc.	ALVR	Biological Products, (No Disgnostic Substances) (2836)	831971007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1755569	Robert John Wilson	C/O Allovir, Inc. 139 Main Street, Suite 500 Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-03-09	52,440	$31.30	5,510,514	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-09	17,480	$31.30	3,197,475	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-09	30,506	$31.70	5,480,008	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-09	10,169	$31.70	3,187,306	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-10	28,403	$30.93	5,451,605	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-10	9,467	$30.93	3,177,839	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-10	25,256	$31.59	5,426,349	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-10	8,419	$31.59	3,169,420	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-10	900	$32.31	5,425,449	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-10	300	$32.31	3,169,120	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-11	10,188	$30.87	5,415,261	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-11	3,397	$30.87	3,165,723	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-11	2,308	$31.63	5,412,953	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-03-11	769	$31.63	3,164,954	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.58 to $31.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held by Meristem Trust Company, LLC as trustee of the John R. Wilson Irrevocable Trust dated July 9, 2020, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.58 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.18 to $31.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held by the Reporting Person as Trustee of the John R. Wilson Revocable Trust Agreement dated August 3, 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.18 to $32.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.275 to $32.325. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.22 to $31.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.22 to $32.125. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.